| Product Code: ETC7657167 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel`s non-injectable insulin import shipments were sourced mainly from Switzerland, UK, Belgium, USA, and Germany. With a low Herfindahl-Hirschman Index (HHI) indicating a competitive market, the compound annual growth rate (CAGR) between 2020-24 was -2.14%. However, there was a slight decline in growth from 2023 to 2024, with a growth rate of -0.41%. Despite the negative growth trend, the diverse sources of imports suggest a stable and competitive market for non-injectable insulin in Israel.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Non-Injectable Insulin Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Non-Injectable Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Non-Injectable Insulin Market - Industry Life Cycle |
3.4 Israel Non-Injectable Insulin Market - Porter's Five Forces |
3.5 Israel Non-Injectable Insulin Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Israel Non-Injectable Insulin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Non-Injectable Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Israel |
4.2.2 Growing adoption of non-injectable insulin due to ease of administration |
4.2.3 Technological advancements in non-injectable insulin delivery systems |
4.3 Market Restraints |
4.3.1 High cost of non-injectable insulin compared to traditional injectable insulin |
4.3.2 Limited reimbursement options for non-injectable insulin |
4.3.3 Regulatory hurdles and approval processes for new non-injectable insulin products |
5 Israel Non-Injectable Insulin Market Trends |
6 Israel Non-Injectable Insulin Market, By Types |
6.1 Israel Non-Injectable Insulin Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Non-Injectable Insulin Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Israel Non-Injectable Insulin Market Revenues & Volume, By Pills, 2021- 2031F |
6.1.4 Israel Non-Injectable Insulin Market Revenues & Volume, By Sprays, 2021- 2031F |
6.1.5 Israel Non-Injectable Insulin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Non-Injectable Insulin Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Israel Non-Injectable Insulin Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 Israel Non-Injectable Insulin Market Revenues & Volume, By Online Stores, 2021- 2031F |
6.2.4 Israel Non-Injectable Insulin Market Revenues & Volume, By Drug Stores, 2021- 2031F |
7 Israel Non-Injectable Insulin Market Import-Export Trade Statistics |
7.1 Israel Non-Injectable Insulin Market Export to Major Countries |
7.2 Israel Non-Injectable Insulin Market Imports from Major Countries |
8 Israel Non-Injectable Insulin Market Key Performance Indicators |
8.1 Patient adherence rates to non-injectable insulin therapy |
8.2 Number of healthcare providers trained in prescribing and administering non-injectable insulin |
8.3 Research and development investments in improving non-injectable insulin formulations |
8.4 Number of partnerships and collaborations between pharmaceutical companies and healthcare providers for non-injectable insulin promotion |
8.5 Patient satisfaction and feedback on non-injectable insulin products |
9 Israel Non-Injectable Insulin Market - Opportunity Assessment |
9.1 Israel Non-Injectable Insulin Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Israel Non-Injectable Insulin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Non-Injectable Insulin Market - Competitive Landscape |
10.1 Israel Non-Injectable Insulin Market Revenue Share, By Companies, 2024 |
10.2 Israel Non-Injectable Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here